Mirum Pharmaceuticals Inc (MIRM)

42.77 +0.73 (+1.74%) USD  |  NASDAQ  |  Jan 03, 16:00
42.77 0.00 (0.00%) After-Hours: 20:00
More

Mirum Pharmaceuticals Research and Development Expense (Quarterly): 31.71M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for MIRM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Cytokinetics Inc --
Amicus Therapeutics Inc 26.16M
Ocugen Inc 8.108M
Scholar Rock Holding Corp 48.72M
Arcutis Biotherapeutics Inc 19.50M